Updated results from the phase 2 CENTAURUS study of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM) Meeting Abstract
| Authors: | Landgren, O.; Cavo, M.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P. M.; Estell, J.; Sandhu, I.; Jenner, M.; Williams, C.; van de Donk, N. W. C. J.; Beksac, M.; Goldschmidt, H.; Moreau, P.; Kuppens, S.; Bandekar, R.; Neff, T.; Cortoos, A.; Clemens, P. L.; Qi, M.; Adams, H. 3rd; Hofmeister, C. C. |
| Abstract Title: | Updated results from the phase 2 CENTAURUS study of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM) |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837605318 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-113467 |
| Notes: | Meeting Abstract: 1994 -- Source: Wos |
